Pioneering Cancer TreatmentAnti-tumor Active Pharmaceutical Ingredients (APIs) are vital in today's medical landscape, addressing one of the most pressing health challenges: cancer. These APIs form ...

Newsday Zimbabwe CANCER patients, including children, have received a boost after two banks and one of Zimbabwe’s leading ...

There are three main types of cancer treatment, including conventional chemotherapy, targeted therapy, and immunotherapy. Conventional chemotherapy uses drugs to kill rapidly dividing cancer cells, ...

A widely used diabetes medication, SGLT2 inhibitors, has shown a surprising benefit for cancer patients—protecting their ...

For nearly 20 years, mesothelioma treatment options were limited to a single regimen: pemetrexed with a platinum agent. Now, there are 3 systemic treatment options available. In this video, Hedy Lee ...

MATTERHORN is the first global phase 3 trial to show improved event-free survival with an immunotherapy combo vs standard ...

In this randomized controlled trial, adjuvant trastuzumab emtansine (T-DM1) reduced invasive disease events in patients with ...

Therapeutics announced plans for a Phase 2 trial evaluating the combination of stenoparib with temozolomide, a DNA-alkylating ...

A new study revealed that of the Medicaid beneficiaries who were recently diagnosed with cancer, 14% received care at a nursing home.

Meanwhile, a New Drug Application (NDA) for another one of Ascentage Pharma’s key drug candidates, the novel Bcl-2 selective inhibitor lisaftoclax (APG-2575), has already been accepted and granted the ...